Unknown PHASE3 INTERVENTIONAL 2-arm NCT04497831

Morphine for Dyspnea in Pulmonary Fibrosis

Determining the Effectiveness of Nebulized Morphine in Treating Dyspnea in Advanced Idiopathic Pulmonary Fibrosis

Sponsor: Medical University of Gdansk

Conditions Idiopathic Pulmonary Fibrosis (IPF)

Interventions Morphine hydrochloride Placebo

Updated 5 times since 2020 Last updated: Jul 30, 2020 Started: Sep 21, 2020 Primary completion: Sep 21, 2022 Completion: Sep 21, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Idiopathic Pulmonary Fibrosis (IPF) and is currently ongoing. Medical University of Gdansk leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Not Yet Recruiting PHASE3
Sep 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Gdansk

Data source: Medical University of Gdansk

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.